[Neoadjuvant and adjuvant treatment of pancreatic cancer].
Neoadjuvante und adjuvante Therapie beim Pankreaskarzinom.
Borderline resectable tumors
Chemoradiotherapy
Chemotherapy
Induction therapy
Resectable tumors
Journal
Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen
ISSN: 1433-0385
Titre abrégé: Chirurg
Pays: Germany
ID NLM: 16140410R
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
pubmed:
18
4
2020
medline:
18
9
2020
entrez:
18
4
2020
Statut:
ppublish
Résumé
Resection is the only curative treatment option for pancreatic cancer patients. Adjuvant chemotherapy can improve disease-free survival and overall survival after resection. Furthermore, neoadjuvant treatment protocols are currently being investigated in a large number of studies. Summary of the current evidence for adjuvant and neoadjuvant treatment. Review of the current scientific literature and guidelines. After resection for pancreatic cancer patients should receive intensive chemotherapy with mFOLFIRINOX, gemcitabine plus capecitabine or gemcitabine/5-fluorouracil (5-FU) monotherapy. Neoadjuvant treatment concepts are promising but have to be further evaluated in prospective studies.
Sections du résumé
BACKGROUND
BACKGROUND
Resection is the only curative treatment option for pancreatic cancer patients. Adjuvant chemotherapy can improve disease-free survival and overall survival after resection. Furthermore, neoadjuvant treatment protocols are currently being investigated in a large number of studies.
OBJECTIVE
OBJECTIVE
Summary of the current evidence for adjuvant and neoadjuvant treatment.
MATERIAL AND METHODS
METHODS
Review of the current scientific literature and guidelines.
RESULTS AND CONCLUSION
CONCLUSIONS
After resection for pancreatic cancer patients should receive intensive chemotherapy with mFOLFIRINOX, gemcitabine plus capecitabine or gemcitabine/5-fluorouracil (5-FU) monotherapy. Neoadjuvant treatment concepts are promising but have to be further evaluated in prospective studies.
Identifiants
pubmed: 32300820
doi: 10.1007/s00104-020-01169-9
pii: 10.1007/s00104-020-01169-9
doi:
Substances chimiques
Fluorouracil
U3P01618RT
Types de publication
Journal Article
Review
Langues
ger
Sous-ensembles de citation
IM